The historical rank and industry rank for Blau Farmaceutica's Net Margin % or its related term are showing as below:
BSP:BLAU3'
s Net Margin % Range Over the Past 10 Years
Min: 7.5 Med: 18.2 Max: 25.83
Current: 12.38
BSP:BLAU3's Net Margin % is ranked better than 74.18% of 972
companies
in the Drug Manufacturers industry
Industry Median: 4.465
vs BSP:BLAU3: 12.38
Blau Farmaceutica Net Margin % Historical Data
The historical data trend for Blau Farmaceutica's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Blau Farmaceutica's Net Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, Blau Farmaceutica's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blau Farmaceutica's Net Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Blau Farmaceutica's Net Margin % distribution charts can be found below:
* The bar in red indicates where Blau Farmaceutica's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blau Farmaceutica (BSP:BLAU3) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Blau Farmaceutica Net Margin % Related Terms
Thank you for viewing the detailed overview of Blau Farmaceutica's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:BLAU3 has been successfully added to your 